The Nasacort brand name has been discontinued in the U.S. as a prescription product, but the active ingredient, triamcinolone acetonide, is still widely available. The story behind Nasacort’s disappearance involves an environmental treaty, a shift from prescription to over-the-counter status, and normal market evolution rather than any safety concern.
The Original Nasacort and the CFC Ban
The first version of Nasacort was a nasal inhaler that used chlorofluorocarbon (CFC) propellants to deliver the medication. CFCs were being phased out worldwide under the Montreal Protocol, an international agreement to protect the ozone layer. Because CFC-based nasal sprays were not considered medically essential, they lost their exemption to continue using the propellant. Aventis, the manufacturer at the time, stopped marketing the original Nasacort Nasal Inhaler as a result.
To replace it, the company developed Nasacort HFA, which used a different, ozone-friendly propellant. They also introduced Nasacort AQ, an aqueous (water-based) spray that didn’t need a propellant at all. Nasacort AQ became the dominant version and the one most people remember.
The Switch to Over-the-Counter
On October 11, 2013, the FDA approved Nasacort Allergy 24HR as an over-the-counter product. This was a significant moment because it made Nasacort one of the first steroid nasal sprays available without a prescription in the United States, beating competitors like Flonase to the pharmacy shelf by about a year and a half.
Once a product goes OTC, the prescription version typically loses its commercial purpose. Insurance coverage changes, doctors stop writing prescriptions for it, and the manufacturer shifts its focus to retail sales. The prescription version of Nasacort was discontinued as a branded product through this transition. The OTC version, Nasacort Allergy 24HR, carried on as essentially the same triamcinolone acetonide nasal spray in new packaging.
What Happened in Other Countries
Nasacort also disappeared from some international markets. In Australia, Nasacort AQ was formally cancelled from the national registry of therapeutic goods in December 2019 by its sponsor, Sanofi-Aventis Australia. When a sponsor cancels a product registration, it can reflect a business decision about profitability, shifting demand, or the availability of generic alternatives rather than a problem with the drug itself.
Triamcinolone Acetonide Is Still Available
If you’re looking for Nasacort on a pharmacy shelf and can’t find the brand name, don’t worry. The active ingredient is the same triamcinolone acetonide that was always in Nasacort, and it’s sold as both the Nasacort Allergy 24HR OTC product and as store-brand generics. Major pharmacy chains carry their own versions at a lower price. The medication works exactly the same way: it reduces inflammation in the nasal passages to relieve congestion, sneezing, runny nose, and itchy nose from allergies.
If you previously had a prescription for Nasacort AQ from your doctor, the OTC version is the same formulation at the same strength. You can pick it up without a prescription. Generic triamcinolone acetonide nasal sprays are also available by prescription if your insurance plan covers them, which can sometimes make the out-of-pocket cost lower than buying OTC.
Why People Think It Was Pulled
The confusion is understandable. When you search for “Nasacort” in drug databases, it shows up as “discontinued,” which sounds alarming. But that label refers specifically to the branded prescription product, not to the medication being removed for safety reasons. The FDA has not withdrawn triamcinolone acetonide nasal spray from the market, and it does not appear on any current drug shortage lists.
The discontinuation was a business and regulatory evolution: an old propellant got banned, the replacement went OTC, and the prescription brand name was retired. The drug itself never went anywhere.